Home›Companies›Biotech & Pharma›Addition Therapeutics

Addition Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 22, 2025·Suggest an edit

About Addition Therapeutics

Addition Therapeutics is a private company based in South San Francisco, California, incorporated in 2021 in Delaware. It has reported $28,000,000 raised in one offering on Form D since December 2025.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Dec 11, 2025Dec 22, 2025$28,000,000fully sold9$3.1MDebt, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Addition Therapeutics's Form D filed Dec 22, 2025.

JP
PB
LK
Lawrence Kong
Secretary
JL
Jennifer Lee
Director
LS
RP
Ronald Park
Executive officer and director

Sources

  1. SECAddition Therapeutics, Inc. filing history